SCHEMBL772391

SCHEMBL772391

CCN1CCCC(C)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12717639 1.00
SCHEMBL14086792 1.00
SCHEMBL24661773 0.93 KDM4E (0.50)
SCHEMBL22254736 0.93 KDM4E (0.50)
SCHEMBL23182993 0.91 KDM4E (0.49)
SCHEMBL30212833 0.87 KDM4E (0.46)
Propionic Acid SCHEMBL6912778 0.87 KDM4E (0.48)
SCHEMBL736581 0.85
SCHEMBL2388285 0.85
SCHEMBL736938 0.85

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 269 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119890422-A Electrolyte membrane for a battery for circulating lithium ions and method for manufacturing same 通用汽车环球科技运作有限责任公司 2025-04-25 CN claimed
CN-111279189-A Marker compositions containing nitrogen compounds and methods of making and using the same 联合色彩制造股份有限公司 2020-06-12 CN claimed
EP-1482931-B1 MONO- AND BICYCLIC AZOLE DERIVATIVES THAT INHIBIT THE INTERACTION OF LIGANDS WITH RAGE TRANSTECH PHARMA INC (US) 2011-10-19 EP claimed
EP-2215085-B1 PYRIDINE AND PYRAZINE DERIVATIVES USEFUL IN THE TREATMENT OF CELL PROLIFERATIVE DISORDERS ASTRAZENECA AB (SE) 2011-09-07 EP claimed
EP-2215085-A2 PYRIDINE AND PYRAZINE DERIVATIVES USEFUL IN THE TREATMENT OF CELL PROLIFERATIVE DISORDERS AstraZeneca AB (SE) 2010-08-11 EP claimed
US-20090118305-A1 PYRIDINE AND PYRAZINE DERIVATIVES - 083 ASTRAZENECA AB (SE) 2009-05-07 US claimed
WO-2009053737-A2 PYRIDINE AND PYRAZINE DERIVATIVES USEFUL IN THE TREATMENT OF CELL PROLIFERATIVE DISORDERS ASTRAZENECA AB (SE) 2009-04-30 WO claimed
EP-1482931-A2 MONO- AND BICYCLIC AZOLE DERIVATIVES THAT INHIBIT THE INTERACTION OF LIGANDS WITH RAGE Transtech Pharma, Inc. (US) 2004-12-08 EP claimed
US-20040082542-A1 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents VTV THERAPEUTICS LLC 2004-04-29 US claimed
WO-2003075921-A2 MONO- AND BICYCLIC AZOLE DERIVATIVES THAT INHIBIT THE INTERACTION OF LIGANDS WITH RAGE TRANSTECH PHARMA, INC. (US) 2003-09-18 WO claimed
CN-119890422-A Electrolyte membrane for a battery for circulating lithium ions and method for manufacturing same 通用汽车环球科技运作有限责任公司 2025-04-25 CN disclosed
EP-3673262-B1 A method of identifying a hydrocarbon fluid with a non-pyrrolidinone nitrogen-containing compound UNITED COLOR MFG INC (US) 2025-03-19 EP disclosed
WO-2024038378-A1 SUBSTITUTED PYRIDINONE COMPOUNDS AS CBL-B INHIBITORS GLENMARK PHARMACEUTICALS LTD (IN) 2024-02-22 WO disclosed
WO-2024020034-A1 CBL-B INHIBITORS AND METHODS OF USE THEREOF ARCUS BIOSCIENCES, INC. (US) 2024-01-25 WO disclosed
WO-2024015851-A1 TREATMENT OF CELL PROLIFERATION-ASSOCIATED CONDITIONS USING A COMBINATION OF A CLB-B INHIBITOR AND AN ADDITIONAL THERAPEUTIC AGENT HOTSPOT THERAPEUTICS, INC. (US) 2024-01-18 WO disclosed
US-4376123-A Hexahydroazepinyloxy-chromones useful as antidepressants MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1983-03-08 US disclosed
US-3988342-A TRANQUILIZERS MERCK & CO., INC. (US) 1976-10-26 US disclosed
US-3981877-A APPETITE STIMULANTS MERCK & CO., INC. (US) 1976-09-21 US disclosed
US-3981876-A ANTIHISTAMINES, APPETITE STIMULANTS MERCK & CO., INC. (US) 1976-09-21 US disclosed
US-3968115-A OR 11)-BROMO-10,11-DIHYDRO-5H-DIBENZO(A,D)-CYCLOHEPTEN-5-YLIDENE PIPERIDINE COMPOUNDSANTIHISTAMINE, APPETITE STIMULANT MERCK & CO., INC. (US) 1976-07-06 US disclosed